Shares of Castle Biosciences fell 6.91% to $60.45 at 12:30 EST on Tuesday, after four consecutive sessions in a row of losses. NASDAQ Composite is dropping 1.09% to $13,762.59, following last session’s downward trend, This seems, up until now, an all-around rough trend exchanging session today.

Castle Biosciences’s last close was $64.94, 78.15% below its 52-week high of $107.69.

The company’s growth estimates for the current quarter and the next is a negative 900% and a negative 150%, respectively.

Castle Biosciences’s Revenue

Year-on-year quarterly revenue growth declined by 1.9%, now sitting on 62.65M for the twelve trailing months.

Castle Biosciences’s Stock Yearly Top and Bottom Value

Castle Biosciences’s stock is valued at $60.45 at 12:30 EST, way under its 52-week high of $107.69 and way above its 52-week low of $26.13.

Castle Biosciences’s Moving Average

Castle Biosciences’s value is way under its 50-day moving average of $71.54 and below its 200-day moving average of $63.56.

More news about Castle Biosciences.

LEAVE A REPLY

Please enter your comment!
Please enter your name here